← Back to Clinical Trials
Recruiting NCT07650149

NCT07650149 Genetic, Microbiological and Behavioral Factors in Obesity

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07650149
Status Recruiting
Phase
Sponsor Jan Kochanowski University
Condition Obesity & Overweight
Study Type OBSERVATIONAL
Enrollment 200 participants
Start Date 2026-05-23
Primary Completion 2027-05

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 60 Years
Study Type OBSERVATIONAL
Interventions
genetic polymorphismgut microbiome

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 200 participants in total. It began in 2026-05-23 with a primary completion date of 2027-05.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study will assess the impact of genetic markers, microbiological (microbiome) and behavioral factors on tolerance, adherence and effectiveness of dual GLP1/GIP RA in the treatment of obesity. 200 consecutive patients who meet all inclusion and none of the exclusion criteria will be enrolled.

Eligibility Criteria

Inclusion criteria * Age 18-60 years * Consent to participate in the study and providing informed written consent * Overweight or obese with a BMI \>27 Exclusion criteria * Contraindications to tirzepatide use: * Type 1 or type 2 diabetes * Pregnancy or breastfeeding * Cancer * Heart failure * Expected lack of patient compliance * Taking immunosuppressive medications, steroids, NSAIDs, antibiotics (within 2 weeks prior to sample collection), * Autoimmune and inflammatory diseases, acute infectious diseases, AIDS, tuberculosis * Mental illness * Alcohol dependence syndrome * Liver cirrhosis * Post-myocardial infarction or stroke

Contact & Investigator

Central Contact

Zbigniew Siudak PI, MD, PhD

✉ zbigniew.siudak@ujk.edu.pl

📞 +48 41 349 6972

Frequently Asked Questions

Who can join the NCT07650149 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 60 Years, studying Obesity & Overweight. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07650149 currently recruiting?

Yes, NCT07650149 is actively recruiting participants. Contact the research team at zbigniew.siudak@ujk.edu.pl for enrollment information.

Where is the NCT07650149 trial being conducted?

This trial is being conducted at Krakow, Poland, Warsaw, Poland.

Who is sponsoring the NCT07650149 clinical trial?

NCT07650149 is sponsored by Jan Kochanowski University. The trial plans to enroll 200 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology